Pedro R Cutillas Selected Research

Biomarkers (Surrogate Marker)

1/2022	eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors.
1/2022	Implementation of Clinical Phosphoproteomics and Proteomics for Personalized Medicine.
1/2018	PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.
3/2014	Environmental stress affects the activity of metabolic and growth factor signaling networks and induces autophagy markers in MCF7 breast cancer cells.
2/2012	Analysis of molecular forms of urine Retinol-Binding Protein in Fanconi Syndrome and design of an accurate immunoassay.
12/2008	Application of proteomic techniques to the study of urine and renal tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro R Cutillas Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 06/2006
6	Leukemia 01/2022 - 08/2012
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 08/2012
5	Fanconi Syndrome (Syndrome, Fanconi) 02/2012 - 05/2003
4	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2014
4	Dent Disease 02/2012 - 05/2003
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
3	Proteinuria 08/2007 - 05/2003
2	Carcinogenesis 11/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 03/2016
2	Disease Progression 01/2018 - 03/2014
1	Neuroblastoma 01/2022
1	Adenocarcinoma 01/2022
1	Cholangiocarcinoma 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Hypopituitarism (Sheehan's Syndrome) 01/2021
1	Liver Diseases (Liver Disease) 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	Retinal Diseases 11/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Heart Failure 10/2017
1	Hyperplasia 12/2016
1	Neointima 12/2016
1	Ascites 03/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2015
1	Hyponatremia 03/2015
1	Hypophosphatemia 03/2015
1	Lymphoma (Lymphomas) 04/2013
1	Multiple Myeloma 04/2013
1	Colorectal Neoplasms (Colorectal Cancer) 03/2013
1	Kidney Diseases (Kidney Disease) 12/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2005

Drug/Important Bio-Agent (IBA)

14	Phosphotransferases (Kinase)IBA 01/2022 - 01/2011
14	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2004
9	Pharmaceutical PreparationsIBA 01/2022 - 06/2006
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2008
6	Peptides (Polypeptides)IBA 10/2017 - 05/2003
5	Protein Kinases (Protein Kinase)IBA 11/2021 - 08/2012
3	Biological ProductsIBA 12/2016 - 03/2013
3	ProteomeIBA 03/2015 - 09/2004
3	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2014 - 08/2005
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2021 - 03/2013
2	CytokinesIBA 01/2018 - 03/2016
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 03/2015 - 02/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2014 - 12/2012
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Gemcitabine FDA Link 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2021
1	belinostatIBA 11/2021
1	CAY10603IBA 11/2021
1	Hormones (Hormone)IBA 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	Clozapine (Clozaril)FDA LinkGeneric 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2020
1	AntioxidantsIBA 10/2020
1	ceric oxide (cerium dioxide)IBA 10/2020
1	ChemokinesIBA 10/2020
1	Poly (ADP-Ribose) Polymerase-1IBA 11/2019
1	ParaffinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	C-terminal proendothelin-1IBA 10/2017
1	Endothelin-1 (Endothelin 1)IBA 10/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	AntigensIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 12/2016
1	Small Interfering RNA (siRNA)IBA 03/2016
1	silmitasertibIBA 03/2016
1	Casein Kinase II (Casein Kinase 2)IBA 03/2016
1	EnzymesIBA 04/2015
1	LipidsIBA 04/2015
1	AlbuminsIBA 03/2015
1	CreatinineIBA 03/2015
1	idelalisibIBA 06/2014
1	p21-Activated KinasesIBA 03/2013
1	Casein Kinases (Casein Kinase)IBA 03/2013
1	PolyaminesIBA 03/2013
1	PutrescineIBA 03/2013
1	SpermidineIBA 03/2013
1	Monoclonal AntibodiesIBA 02/2012
1	Ifosfamide FDA LinkGeneric 08/2007
1	pervanadateIBA 08/2005
1	PhosphoproteinsIBA 08/2005

Therapy/Procedure

10	Therapeutics 01/2022 - 06/2006
1	Mammaplasty (Breast Reconstruction) 01/2020
1	Precision Medicine 01/2020
1	Drug Therapy (Chemotherapy) 01/2017